Jill Goldman

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease

The Importance of Offering Genetic Counseling and Testing to All Persons Diagnosed With Frontotemporal Degeneration Spectrum Disorders

Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration

Data stewardship in FTLD research: Investigator and research participant views

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion

Proposed research criteria for prodromal behavioural variant frontotemporal dementia

Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia

Utility of the global CDR^® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort

An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification

Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia Type 2 in a Family With Full CAG Repeat Expansions of<i>ATXN2</i>